🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Laura W. Goff

Vanderbilt University Medical Center

ORCID: 0000-0001-6719-1479
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers”.

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383
N/A
1.1DataRank · unranked
51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

A clinical score (CS) for patients with well-differentiated neuroendocrine tumors (WD NETs) under consideration for peptide receptor radionuclide therapy (PRRT) with Lu 177-dotatate.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.363
N/A
0DataRank · unranked
1 citations

Liping Du, Aimee Schad, Shikha Jain, Aaron Jessop, Chirayu Shah +9 more

Validation of a clinical score (CS) for patients (pts) with well-differentiated neuroendocrine tumors (WD NETs) under consideration for peptide receptor radionuclide therapy (PRRT) with Lu 177 dotatate.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4109
N/A
0DataRank · unranked
0 citations

Aman Chauhan, Liping Du, Katharine Thomas, Aasems Jacob, Aimee Schad +13 more

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.lba490
N/A
0DataRank · unranked
99 citations

Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin +15 more

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies

Cancers(2023)10.3390/cancers15133312
N/A
0DataRank · unranked
43 citations

Rajiv Agarwal, Laura W. Goff, Thatcher Heumann, Justin H. Lo

Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad046
N/A
0DataRank · unranked
28 citations

Leontios Pappas, Islam Baiev, Jordan R. Maurer, Andrea Grace Bocobo, Karen Zhang +25 more

Targeted therapies in advanced biliary tract cancers—a narrative review

Chinese Clinical Oncology(2023)10.21037/cco-22-93
N/A
0DataRank · unranked
19 citations

Thatcher Heumann, Laura W. Goff, Rajiv Agarwal, Michael LaPelusa

Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma

Current Treatment Options in Oncology(2024)10.1007/s11864-023-01153-5
N/A
0DataRank · unranked
23 citations

Rajiv Agarwal, Laura W. Goff, Natalie A. Lockney, Chandrasekhar Padmanabhan, Thatcher Heumann +1 more

Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma

Advances in Oncology(2024)10.1016/j.yao.2024.02.002
N/A
0DataRank · unranked
2 citations

Rajiv Agarwal, Sara Brown, Anthony J. Borgmann, Natalie A. Lockney, Laura W. Goff +2 more

Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma

Advances in Oncology(2024)10.1016/j.yao.2024.02.001
N/A
0DataRank · unranked
0 citations

Rajiv Agarwal, Laura W. Goff, Thatcher Heumann, Daenielle Lang

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3133
N/A
0DataRank · unranked
16 citations

Seong-Woo Bae, Jennifer G. Whisenant, Gregory D. Ayers, Quanhu Sheng, Todd E. Peterson +15 more

End-of-life (EOL) outcomes and healthcare utilization for patients with hepatocellular carcinoma (HCC) who received immune checkpoint inhibition (ICI).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.4_suppl.560
N/A
0DataRank · unranked
0 citations

Anna-Carson Rimer Uhelski, Sarah K. Cimino, Henry J. Domenico, Sara Martin, Mohana Karlekar +5 more

First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-11C]-Glutamine in Patients with Metastatic Colorectal Cancer

Journal of Nuclear Medicine(2021)10.2967/jnumed.120.261594
N/A
0DataRank · unranked
30 citations

Joe Grudzinski, Gary T. Smith, Todd E. Peterson, Jennifer G. Whisenant, Tiffany L. Hickman +9 more

End‐Of‐Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition

Cancer Medicine(2025)10.1002/cam4.71293
N/A
0DataRank · unranked
0 citations

Anna-Carson Rimer Uhelski, Sarah K. Cimino, Henry J. Domenico, Sara Martin, Mohana Karlekar +5 more